Compounds > centa
Page last updated: 2024-09-04

centa and nitrocefin

centa has been researched along with nitrocefin in 5 studies

Compound Research Comparison

Studies
(centa)		Trials
(centa)		Recent Studies (post-2010)
(centa)		Studies
(nitrocefin)		Trials
(nitrocefin)		Recent Studies (post-2010) (nitrocefin)
804203056

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bebrone, C; Delbrück, H; Fischer, R; Frère, JM; Galleni, M; Hoffmann, KM; Kupper, MB; Schlömer, P; Willmann, C1
Brem, J; Cain, R; Fishwick, CW; Owens, RJ; Rydzik, AM; Salimraj, R; Schofield, CJ; Spencer, J; van Berkel, SS; Verma, A1
Bayer, A; Christopeit, T; Guttormsen, Y; Leiros, HK; Lund, BA1
Barry, AL; Jones, RN; Novick, WJ; Thornsberry, C; Wilson, HW1
Bebrone, C; Docquier, JD; Fastrez, J; Frère, JM; Galleni, M; Mahy, F; Moali, C; Pratt, RF; Rival, S; Rossolini, GM1

Other Studies

5 other study(ies) available for centa and nitrocefin

ArticleYear
The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Aeromonas hydrophila; Bacterial Proteins; beta-Lactamases; Binding Sites; Calorimetry, Differential Scanning; Circular Dichroism; Crystallography, X-Ray; Histidine; Kinetics; Mutagenesis, Site-Directed; Protein Binding; Protein Structure, Secondary; Zinc

2009
Assay platform for clinically relevant metallo-β-lactamases.
    Journal of medicinal chemistry, 2013, Sep-12, Volume: 56, Issue:17

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metals

2013
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
    Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance

2016
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.
    Journal of clinical microbiology, 1982, Volume: 15, Issue:5

    Topics: Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Citrobacter; Drug Evaluation, Preclinical; Enterobacteriaceae; Escherichia coli; Evaluation Studies as Topic; Indicators and Reagents; Klebsiella; Proteus mirabilis

1982
CENTA as a chromogenic substrate for studying beta-lactamases.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:6

    Topics: beta-Lactamases; Cephalosporins; Chromogenic Compounds; Indicators and Reagents; Kinetics; Mycobacterium tuberculosis; Pseudomonas aeruginosa; Staphylococcus aureus

2001